Clinical Trials Directory

Trials / Sponsors / Juventas Cell Therapy Ltd.

Juventas Cell Therapy Ltd.

Industry · 14 registered clinical trials — 10 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Study of HY001N in the Treatment of Relapsed or Refractory Neurological Autoimmune Diseases
Neurological Autoimmune Diseases
EARLY_Phase 12025-12-30
Not Yet RecruitingInaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After Three or More Lines
AIHA - Cold Autoimmune Hemolytic Anemia
Phase 12025-12-27
WithdrawnClinical Trial of HY004 Cell Injection in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphom
Non-hodgkin Lymphoma
Phase 1 / Phase 22025-09-01
WithdrawnA Study of HY004 Treatment in Adult Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r B-ALL)
B-cell Acute Lymphoblastic Leukemia
Phase 1 / Phase 22025-06-30
RecruitingInaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune
Autoimmune Thrombocytopenia
Phase 12025-03-01
RecruitingA Study of CNCT19 in the Treatment of Relapsed or Refractory Neurological Autoimmune Diseases
Neurological Autoimmune Diseases
EARLY_Phase 12025-03-01
RecruitingInaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia
B-cell Acute Lymphoblastic Leukemia
—2024-06-05
RecruitingLong-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection
B-cell Tumors
—2024-03-30
RecruitingA Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)
B-cell Acute Lymphoblastic Leukemia
Phase 1 / Phase 22023-02-07
RecruitingExploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases
Lupus Erythematosus, Systemic
EARLY_Phase 12021-12-14
RecruitingClinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemi
Relapsed or Refractory Acute Lymphoblastic Leukemia
Phase 22020-12-24
RecruitingPhase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymp
Non-Hodgkin's Lymphoma
Phase 22020-10-26
CompletedA Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Acute Lymphoblastic
Relapsed or Refractory Acute Lymphoblastic Leukemia
Phase 12020-03-13
CompletedA Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Diffuse Non-Hodgkin
Diffuse Non-Hodgkin Lymphoma
Phase 12020-01-15